Researchers have found in a phase 3 trial that phentolamine ophthalmic solution 0.75% led to significant improvements in ...

“Our collaboration with Kinetiq and Pier Two marks a strategic step in realizing a shared vision for secure, composable, and deeply integrated liquid staking on Hyperliquid,” said Hyunsu Jung, Chief ...

Methods Forty consecutive patients with moderate to severe DED were included in a phase IIa, prospective, open label, multiple-dose, clinical trial to receive rhNGF eye drops at 20 µg/mL (Group 1: G1) ...

Stuart Therapeutics has reported initial findings from its 29-day randomised Phase III trial of the ST-100 (vezocolmitide) ...

Stuart Therapeutics’ dry eye disease drug has failed to demonstrate that it can increase tear production in a phase 3 test.

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage ...

A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...

Topline data were announced from a phase 3 trial evaluating ST-100 ophthalmic solution for the treatment of dry eye disease.

Ocular Surgery News OSN | Find ophthalmology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.